Skip to main content
Premium Trial:

Request an Annual Quote

Correlia Biosystems Closes $7M Series A Round

NEW YORK – Proteomics firm Correlia Biosystems said on Friday that it has closed a $7 million Series A funding found.

The company said that the round, which was led by Neotribe Ventures and was joined by Cota Capital, the Regents of the University of California, and others, will support the commercial launch of the company's miniaturized ELISA platform.

By miniaturizing ELISA testing, Correlia reduces the time and sample volume required to run these commonly used protein assays.

"With this new funding round, we are poised to bring our unique, more granular assay capabilities to customers who have been waiting for major advances in the 50-year old ELISA market," Correlia CEO Akwasi Apori said in a statement.

"We are excited to join Correlia's journey to create a category-creating new standard for ultra-efficient and highly automated protein biomarker measurement," Swaroop Kolluri, founder and managing director of Neotribe, said in a statement.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.